Lansoprazol Vir Pharma

Lansoprazole, the active ingredient in Lansoprazol Vir Pharma, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders in adults and adolescents. GNH USA supplies Lansoprazol Vir Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole acts on the gastric proton pump to lower acid production, making it useful for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): reduces acid exposure, relieving heartburn and regurgitation. - Peptic ulcer disease: promotes ulcer healing by maintaining a less acidic gastric environment. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations used to eradicate H. pylori. - Erosive esophagitis: facilitates mucosal healing by decreasing reflux‑induced injury.

Adverse reactions may occur with Lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhea: loose stools that usually resolve with continued therapy. - Nausea: feeling of queasiness, may improve over time. - Abdominal pain: discomfort in the stomach region.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and breathing difficulty. - Low magnesium levels (hypomagnesemia): can cause muscle cramps, irregular heartbeat, or seizures. - Clostridioides difficile infection: severe diarrhea and colitis, requiring medical attention.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with severe renal impairment. - Magnesium monitoring: check serum magnesium during prolonged treatment. - Elderly caution: increased susceptibility to adverse effects, especially electrolyte disturbances. - Drug interaction awareness: avoid concomitant use with medications that require gastric acidity for absorption. - Storage: Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole may interact with several medicines; awareness of interaction severity is essential.

Major Interactions (Avoid): - Atazanavir: reduced antiviral absorption and efficacy. - Ketoconazole: markedly decreased antifungal absorption. - Clopidogrel: diminished antiplatelet activity, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect, monitor INR. - Phenytoin: possible reduction in phenytoin levels, watch for seizure control. - Digoxin: may increase serum digoxin concentrations, assess for toxicity.